The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Present and future therapies of hepatitis B: From discovery to cure
Open accessAbstract
Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million people worldwide. While treatment for HBV has improved, HBV patients often require lifelong therapies and cure is still a challenging goal. Recent advances in technologies and pharmaceutical sciences have heralded a new horizon of innovative therapeutic approaches that are bringing us closer to the possibility of a functional cure of chronic HBV infection. In this article, we review the current state of science in HBV therapy and highlight new and exciting therapeutic strategies spurred by recent scientific advances. Some of these therapies have already entered into clinical phase, and we will likely see more of them moving along the development pipeline. Conclusion: With growing interest in developing and efforts to develop more effective therapies for HBV, the challenging goal of a cure may be well within reach in the near future.(H epatology 2015;62:1893–1908)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationLamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., et al. (2012) · eLife · doi:10.7554/elife.00049 · Cited by 2,115
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Self-citationMarcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Peck, M., Craxì, A., Fried, M., & Zeuzem, S. (2013) · Cited by 1,079
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
Self-citationSpecific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Lucifora, J., Xia, Y., Reisinger, F., Zhang, K., Stadler, D., Cheng, X., Sprinzl, M. F., Koppensteiner, H., Makowska, Z., Volz, T., et al. (2014) · Science · doi:10.1126/science.1243462 · Cited by 893
Self-citationThe natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 876
Self-citationAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Liaw, Y.-F., Leung, N., Kao, J.-H., Piratvisuth, T., Gane, E., Han, K.-H., Guan, R., Lau, G. K. K., Locarnini, S., & for the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver (2008) · Hepatology International · doi:10.1007/s12072-008-9080-3 · Cited by 867
Self-citationLarge surface proteins of hepatitis B virus containing the pre-s sequence
Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H., & Gerlich, W. H. (1984) · Journal of Virology · doi:10.1128/jvi.52.2.396-402.1984 · Cited by 823
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Ni, Y., Lempp, F. A., Mehrle, S., Nkongolo, S., Kaufman, C., Fälth, M., Stindt, J., Königer, C., Nassal, M., Kubitz, R., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.024 · Cited by 781
Self-citationInhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Belloni, L., Allweiss, L., Guerrieri, F., Pediconi, N., Volz, T., Pollicino, T., Petersen, J., Raimondo, G., Dandri, M., & Levrero, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58847 · Cited by 577
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
Deres, K., Schröder, C. H., Paessens, A., Goldmann, S., Hacker, H. J., Weber, O., Krämer, T., Niewöhner, U., Pleiss, U., Stoltefuss, J., et al. (2003) · Science · doi:10.1126/science.1077215 · Cited by 508
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Belloni, L., Pollicino, T., De Nicola, F., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., & Levrero, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908365106 · Cited by 498
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection
Lucifora, J., Arzberger, S., Durantel, D., Belloni, L., Strubin, M., Levrero, M., Zoulim, F., Hantz, O., & Protzer, U. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.015 · Cited by 481
Self-citationBertoletti, A., & Ferrari, C. (2012) · Gut · doi:10.1136/gutjnl-2011-301073 · Cited by 477
Pollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., & Levrero, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.001 · Cited by 472
Xu, D., Fu, J., Jin, L., Zhang, H., Zhou, C., Zou, Z., Zhao, J.-M., Zhang, B., Shi, M., Ding, X., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.739 · Cited by 448
Schulze, A., Gripon, P., & Urban, S. (2007) · Hepatology · doi:10.1002/hep.21896 · Cited by 445
Self-citationInhibition of Hepatitis B Virus Replication by APOBEC3G
Turelli, P., Mangeat, B., Jost, S., Vianin, S., & Trono, D. (2004) · Science · doi:10.1126/science.1092066 · Cited by 433
Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
Self-citationNakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M. E., Kaminski, M., Gostick, E., Price, D. A., Freeman, G. J., Wherry, E. J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000313 · Cited by 380
Self-citationLanford, R. E., Guerra, B., Chavez, D., Giavedoni, L., Hodara, V. L., Brasky, K. M., Fosdick, A., Frey, C. R., Zheng, J., Wolfgang, G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.003 · Cited by 377
Structural organization of the hepatitis B virus minichromosome
Bock, C. T., Schwinn, S., Locarnini, S., Fyfe, J., Manns, M. P., Trautwein, C., & Zentgraf, H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4481 · Cited by 361
Self-citationStrategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.030 · Cited by 361
Self-citationSeto, W.-K., Chan, T. S. Y., Hwang, Y.-Y., Wong, D. K.-H., Fung, J., Liu, K. S.-H., Gill, H., Lam, Y.-F., Lie, A. K. W., Lai, C.-L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.7081 · Cited by 332
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J., & Harris, R. S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1744 · Cited by 328
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
Gill, S., & June, C. H. (2015) · Immunological Reviews · doi:10.1111/imr.12243 · Cited by 320
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
Kennedy, P. T. F., Sandalova, E., Jo, J., Gill, U., Ushiro–Lumb, I., Tan, A. T., Naik, S., Foster, G. R., & Bertoletti, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.009 · Cited by 307
Bengsch, B., Martin, B., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.005 · Cited by 284
Ning, Q., Han, M., Sun, Y., Jiang, J., Tan, D., Hou, J., Tang, H., Sheng, J., & Zhao, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.044 · Cited by 275
Chan, H. L.-Y., Leung, N. W.-Y., Hui, A. Y., Wong, V. W.-S., Liew, C.-T., Chim, A. M.-L., Chan, F. K.-L., Hung, L. C.-T., Lee, Y.-T., Tam, J. S.-L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00006 · Cited by 272
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
Stray, S. J., Bourne, C. R., Punna, S., Lewis, W. G., Finn, M. G., & Zlotnick, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409732102 · Cited by 267
Watashi, K., Sluder, A., Daito, T., Matsunaga, S., Ryo, A., Nagamori, S., Iwamoto, M., Nakajima, S., Tsukuda, S., Borroto-Esoda, K., et al. (2014) · Hepatology · doi:10.1002/hep.26982 · Cited by 266
Involvement of host cellular multivesicular body functions in hepatitis B virus budding
Watanabe, T., Sorensen, E. M., Naito, A., Schott, M., Kim, S., & Ahlquist, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704000104 · Cited by 263
Moraleda, G., Saputelli, J., Aldrich, C. E., Averett, D., Condreay, L., & Mason, W. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9392-9399.1997 · Cited by 263
Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072076 · Cited by 256
Nkongolo, S., Ni, Y., Lempp, F. A., Kaufman, C., Lindner, T., Esser-Nobis, K., Lohmann, V., Mier, W., Mehrle, S., & Urban, S. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.022 · Cited by 255
Self-citationMicco, L., Peppa, D., Loggi, E., Schurich, A., Jefferson, L., Cursaro, C., Panno, A. M., Bernardi, M., Brander, C., Bihl, F., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.029 · Cited by 253
Königer, C., Wingert, I., Marsmann, M., Rösler, C., Beck, J., & Nassal, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409986111 · Cited by 239
MacDONALD, R. A. (1961) · Archives of Internal Medicine · doi:10.1001/archinte.1961.03620030023003 · Cited by 230
Krebs, K., Böttinger, N., Huang, L., Chmielewski, M., Arzberger, S., Gasteiger, G., Jäger, C., Schmitt, E., Bohne, F., Aichler, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.047 · Cited by 227
Kinetics of Hepadnavirus Loss from the Liver during Inhibition of Viral DNA Synthesis
Zhu, Y., Yamamoto, T., Cullen, J., Saputelli, J., Aldrich, C. E., Miller, D. S., Litwin, S., Furman, P. A., Jilbert, A. R., & Mason, W. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.311-322.2001 · Cited by 226
Blank, A., Markert, C., Hohmann, N., Carls, A., Mikus, G., Lehr, T., Alexandrov, A., Haag, M., Schwab, M., Urban, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.013 · Cited by 221
Self-citationCai, D., Mills, C., Yu, W., Yan, R., Aldrich, C. E., Saputelli, J. R., Mason, W. S., Xu, X., Guo, J.-T., Block, T. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00473-12 · Cited by 220
Self-citationSung, J. J. Y., Wong, M.-L., Bowden, S., Liew, C.-T., Hui, A. Y., Wong, V. W. S., Leung, N. W. Y., Locarnini, S., & Chan, H. L. Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.009 · Cited by 218
Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection
Lopes, A. R., Kellam, P., Das, A., Dunn, C., Kwan, A., Turner, J., Peppa, D., Gilson, R. J., Gehring, A., Bertoletti, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33402 · Cited by 218
Vaz, F. M., Paulusma, C. C., Huidekoper, H., de Ru, M., Lim, C., Koster, J., Ho‐Mok, K., Bootsma, A. H., Groen, A. K., Schaap, F. G., et al. (2015) · Hepatology · doi:10.1002/hep.27240 · Cited by 217
Qasim, W., Brunetto, M., Gehring, A. J., Xue, S.-A., Schurich, A., Khakpoor, A., Zhan, H., Ciccorossi, P., Gilmour, K., Cavallone, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.001 · Cited by 208
Yan, H., Peng, B., He, W., Zhong, G., Qi, Y., Ren, B., Gao, Z., Jing, Z., Song, M., Xu, G., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03540-12 · Cited by 202
Myristylation of the Hepatitis B Virus Large Surface Protein Is Essential for Viral Infectivity
GRIPON, P., LE SEYEC, J., RUMIN, S., & GUGUEN-GUILLOUZO, C. (1995) · Virology · doi:10.1006/viro.1995.0002 · Cited by 197
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Gane, E. J., Lim, Y.-S., Gordon, S. C., Visvanathan, K., Sicard, E., Fedorak, R. N., Roberts, S., Massetto, B., Ye, Z., Pflanz, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.037 · Cited by 190
HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells
Xu, Y., Hu, Y., Shi, B., Zhang, X., Wang, J., Zhang, Z., Shen, F., Zhang, Q., Sun, S., & Yuan, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.031 · Cited by 183
T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes
Bohne, F., Chmielewski, M. M., Ebert, G., Wiegmann, K., Kürschner, T., Schulze, A., Urban, S., Krönke, M., Abken, H., & Protzer, U. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.002 · Cited by 183
Self-citationHuang, H.-C., Chen, C.-C., Chang, W.-C., Tao, M.-H., & Huang, C. (2012) · Journal of Virology · doi:10.1128/jvi.00873-12 · Cited by 182
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stray, S. J., & Zlotnick, A. (2006) · Journal of Molecular Recognition · doi:10.1002/jmr.801 · Cited by 182
Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
Campagna, M. R., Liu, F., Mao, R., Mills, C., Cai, D., Guo, F., Zhao, X., Ye, H., Cuconati, A., Guo, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00582-13 · Cited by 180
Self-citationVandepapelière, P., Lau, G. K. K., Leroux-Roels, G., Horsmans, Y., Gane, E., Tawandee, T., Merican, M. I. B., Win, K. M., Trepo, C., Cooksley, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.072 · Cited by 180
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA
Klein, C., Bock, C. T., Wedemeyer, H., Wüstefeld, T., Locarnini, S., Dienes, H. P., Kubicka, S., Manns, M. P., & Trautwein, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00720-0 · Cited by 174
Self-citationChan, H. L. Y., Chan, C. K., Hui, A. J., Chan, S., Poordad, F., Chang, T.-T., Mathurin, P., Flaherty, J. F., Lin, L., Corsa, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.044 · Cited by 172
DNA vaccines: developing new strategies to enhance immune responses
Abdulhaqq, S. A., & Weiner, D. B. (2008) · Immunologic Research · doi:10.1007/s12026-008-8076-3 · Cited by 167
Nucleoporin 153 Arrests the Nuclear Import of Hepatitis B Virus Capsids in the Nuclear Basket
Schmitz, A., Schwarz, A., Foss, M., Zhou, L., Rabe, B., Hoellenriegel, J., Stoeber, M., Panté, N., & Kann, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000741 · Cited by 166
Brouwer, W. P., Xie, Q., Sonneveld, M. J., Zhang, N., Zhang, Q., Tabak, F., Streinu‐Cercel, A., Wang, J., Idilman, R., Reesink, H. W., et al. (2015) · Hepatology · doi:10.1002/hep.27586 · Cited by 166
Menéndez-Arias, L., Álvarez, M., & Pacheco, B. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.04.005 · Cited by 163
Liu, F., Campagna, M., Qi, Y., Zhao, X., Guo, F., Xu, C., Li, S., Li, W., Block, T. M., Chang, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003613 · Cited by 161
Self-citationLok, A. S., Trinh, H., Carosi, G., Akarca, U. S., Gadano, A., Habersetzer, F., Sievert, W., Wong, D., Lovegren, M., Cohen, D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.037 · Cited by 159
Self-citationChen, J., Zhang, W., Lin, J., Wang, F., Wu, M., Chen, C., Zheng, Y., Peng, X., Li, J., & Yuan, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2013.212 · Cited by 159
Delaney, W. E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G., & Locarnini, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3057-3060.2002 · Cited by 158
Self-citationThe phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
Feld, J. J., Colledge, D., Sozzi, V., Edwards, R., Littlejohn, M., & LOCARNINI, S. A. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.06.014 · Cited by 155
Self-citationSlijepcevic, D., Kaufman, C., Wichers, C. G. K., Gilglioni, E. H., Lempp, F. A., Duijst, S., de Waart, D. R., Elferink, R. P. J. O., Mier, W., Stieger, B., et al. (2015) · Hepatology · doi:10.1002/hep.27694 · Cited by 155
Self-citationPD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
Tzeng, H.-T., Tsai, H.-F., Liao, H., Lin, Y.-J., Chen, L., Chen, P., & Hsu, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039179 · Cited by 152
Xu, D.-Z., Wang, X., Shen, X., Gong, G., Ren, H., Guo, L., Sun, A.-M., Xu, M., Li, L., Guo, X., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.003 · Cited by 149
Katen, S. P., Tan, Z., Chirapu, S. R., Finn, M. G., & Zlotnick, A. (2013) · Structure · doi:10.1016/j.str.2013.06.013 · Cited by 145
King, R. W., Ladner, S. K., Miller, T. J., Zaifert, K., Perni, R. B., Conway, S. C., & Otto, M. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3179 · Cited by 144
Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells
Macovei, A., Radulescu, C., Lazar, C., Petrescu, S. M., Durantel, D., Dwek, R. A., Zitzmann, N., & Nichita, N. B. (2009) · Journal of Virology · doi:10.1128/jvi.01207-09 · Cited by 143
Blanchet, M., & Sureau, C. (2007) · Journal of Virology · doi:10.1128/jvi.00096-07 · Cited by 137
Entry inhibitors and their use in the treatment of HIV-1 infection
Haqqani, A. A., & Tilton, J. C. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.017 · Cited by 135
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
Chotiyaputta, W., Peterson, C., Ditah, F. A., Goodwin, D., & Lok, A. S.-F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.016 · Cited by 135
Self-citationHalperin, S. A., Dobson, S., McNeil, S., Langley, J. M., Smith, B. R., McCall-Sani, R., Levitt, D., Nest, G. V., Gennevois, D., & Eiden, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.095 · Cited by 134
Döring, B., Lütteke, T., Geyer, J., & Petzinger, E. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00004-1 · Cited by 132
Host factors involved in hepatitis B virus maturation, assembly, and egress
Prange, R. (2012) · Medical Microbiology and Immunology · doi:10.1007/s00430-012-0267-9 · Cited by 130
RNAi for Treating Hepatitis B Viral Infection
Chen, Y., Cheng, G., & Mahato, R. I. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9504-0 · Cited by 130
STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus
Guo, F., Han, Y., Zhao, X., Wang, J., Liu, F., Xu, C., Wei, L., Jiang, J., Block, T. M., Guo, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04321-14 · Cited by 130
Self-citationPreclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
Wu, G., Liu, B., Zhang, Y., Li, J., Arzumanyan, A. L., Clayton, M. M., Schinazi, R. F., Wang, Z., Goldmann, S., Ren, Q., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01091-13 · Cited by 130
Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver
Magami, Y., Azuma, T., Inokuchi, H., Kokuno, S., Moriyasu, F., Kawai, K., & Hattori, T. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01702.x · Cited by 126
Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
Vanderlinden, E., & Naesens, L. M. J. (2013) · Medicinal Research Reviews · doi:10.1002/med.21289 · Cited by 124
Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Xu, C., Guo, H., Pan, X., Mao, R., Yu, W., Xu, X., Wei, L., Chang, J., Block, T. M., & Guo, J. (2010) · Journal of Virology · doi:10.1128/jvi.00918-10 · Cited by 123
Self-citationWeber, N. D., Stone, D., Sedlak, R. H., Feelixge, H. S. D. S., Roychoudhury, P., Schiffer, J. T., Aubert, M., & Jerome, K. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097579 · Cited by 122
Reasons to consider earlier treatment of chronic HBV infections
Zoulim, F., & Mason, W. S. (2011) · Gut · doi:10.1136/gutjnl-2011-300937 · Cited by 120
Self-citationEzetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
Lucifora, J., Esser, K., & Protzer, U. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.008 · Cited by 118
Management of Hepatitis B: Our Practice and How It Relates to the Guidelines
Yapalı, S., Talaat, N., & Lok, A. S.-F. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.036 · Cited by 116
Self-citationXu, D.-Z., Zhao, K., Guo, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002565 · Cited by 114
The Host–pathogen Interaction during HBV Infection: Immunological Controversies
Bertoletti, A., Maini, M. K., & Ferrari, C. I. (2010) · Antiviral Therapy · doi:10.3851/imp1620 · Cited by 112
A Function Essential to Viral Entry Underlies the Hepatitis B Virus “a” Determinant
Salisse, J., & Sureau, C. (2009) · Journal of Virology · doi:10.1128/jvi.00678-09 · Cited by 112
Yang, S.-H., Lee, C.-G., Park, S.-H., Im, S.-J., Kim, Y.-M., Son, J.-M., Wang, J.-S., Yoon, S.-K., Song, M.-K., Ambrozaitis, A., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302751 · Cited by 111
Tavis, J. E., Cheng, X., Hu, Y., Totten, M., Cao, F., Michailidis, E., Aurora, R., Meyers, M. J., Jacobsen, E. J., Parniak, M. A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003125 · Cited by 111
Vanwolleghem, T., Hou, J., van Oord, G., Andeweg, A. C., Osterhaus, A. D. M. E., Pas, S. D., Janssen, H. L. A., & Boonstra, A. (2015) · Hepatology · doi:10.1002/hep.27805 · Cited by 110
Schieck, A., Schulze, A., Gähler, C., Müller, T. H., Haberkorn, U., Alexandrov, A., Urban, S., & Mier, W. (2013) · Hepatology · doi:10.1002/hep.26211 · Cited by 109
Self-citationImpaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
Hirsch, I., Caux, C., Hasan, U. A., Bendriss‐Vermare, N., & Olive, D. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.07.004 · Cited by 109
Martin, P., Dubois, C., Jacquier, E., Dion, S., Bourgine, M., Godon, O., Kratzer, R., Lélu, K., Evlachev, A., Méritet, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308041 · Cited by 106
Thimme, R., & Dandri, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.007 · Cited by 106
Fontaine, H., Kahi, S., Chazallon, C., Bourgine, M., Varaut, A., Buffet, C., Godon, O., Méritet, J., Saïdi, Y., Michel, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305707 · Cited by 105
Gaggar, A., Coeshott, C. M., Apelian, D., Rodell, T. C., Armstrong, B. R., Shen, G., Subramanian, G. M., & McHutchison, J. G. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.027 · Cited by 99
Kosinska, A. D., Zhang, E., Johrden, L., Liu, J., Seiz, P. L., Zhang, X., Ma, Z., Kemper, T., Fiedler, M., Glebe, D., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003391 · Cited by 98
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection
Gehring, A. J., Haniffa, M. A., Kennedy, P. T. F., Ho, Z. Z., Boni, C., Shin, A., Banu, N., Chia, A., Lim, S. G., Ferrari, C. I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66043 · Cited by 98
Koh, S., Shimasaki, N., Suwanarusk, R., Ho, Z. Z., Chia, A., Banu, N., Howland, S. W., Ong, A. S. M., Gehring, A. J., Stauss, H. J., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.43 · Cited by 97
Horiike, N., Akbar, S. M. F., Michitaka, K., et al. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.07.004 · Cited by 84
Galun, E., Eren, R., Safadi, R., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.31867 · Cited by 81
Billioud, G., Pichoud, C., Puerstinger, G., Neyts, J. H., & Zoulim, F. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.012 · Cited by 80
Self-citationRNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
Liang, G., KITAMURA, K., Wang, Z., Liu, G., Chowdhury, S., Fu, W., Koura, M., Wakae, K., Honjo, T., & Muramatsu, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221921110 · Cited by 70
Dual effect of APOBEC3G on Hepatitis B virus
Noguchi, C., Hiraga, N., Mori, N., Tsuge, M., Imamura, M., Takahashi, S., Fujimoto, Y., Ochi, H., Abe, H., MAEKAWA, T., et al. (2007) · Journal of General Virology · doi:10.1099/vir.0.82319-0 · Cited by 66
Yoon, S. K., Seo, Y. B., Im, S. J., Bae, S. H., Song, D. S., You, C. R., Jang, J., Yang, S. H., Suh, Y. S., Song, J. S., et al. (2014) · Liver International · doi:10.1111/liv.12530 · Cited by 62
Dissecting the dendritic cell controversy in chronic hepatitis B virus infection
Gehring, A. J., & D’Angelo, J. A. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.95 · Cited by 57
Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
Bertoletti, A., & Gehring, A. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003784 · Cited by 55
Strategies to Eliminate HBV Infection
Kapoor, R., & Kottilil, S. (2014) · Future Virology · doi:10.2217/fvl.14.36 · Cited by 55
Hao, J., Jin, W., Li, X., Wang, S., Zhang, X., Fan, H., Li, C., Chen, L., Gao, B., Liu, G., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01710-12 · Cited by 50
Renard, M., Henry, M., Guétard, D., Vartanian, J., & Wain–Hobson, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.029 · Cited by 44
Baxevanis, C. N., Voutsas, I. F., & Tsitsilonis, O. (2013) · Immunotherapy · doi:10.2217/imt.13.24 · Cited by 43
Mason, W. S., Xu, C., Low, H. C., Saputelli, J. R., Aldrich, C. E., Scougall, C. A., Große, A., Colonno, R. J., Litwin, S., & Jilbert, A. R. (2008) · Journal of Virology · doi:10.1128/jvi.01587-08 · Cited by 40
a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20
Bogomolov, P., Воронкова, Н. В., Allweiss, L., et al. (2014) · Hepatology · Cited by 29
Zoulim, F., Luangsay, S., & Durantel, D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.028 · Cited by 27
Self-citationNorton, P. A., Menne, S., Sinnathamby, G., Rodemich-Betesh, L., Côté, P. J., Philip, R., Mehta, A. S., Tennant, B. C., & Block, T. M. (2010) · Hepatology · doi:10.1002/hep.23806 · Cited by 19
Self-citationHepatitis B Immunology for Clinicians
Chang, K. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.012 · Cited by 16
Self-citationBourlière, M., Rabiéga, P., Ganne‐Carrié, N., Serfaty, L., Marcellin, P., Pouget, N., Guyader, D., Hézode, C., Picon, M., Causse, X., et al. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30131-8 · Cited by 14
Self-citationBrouwer, W. P., Xie, Q., Sonneveld, M. J., Zhang, N. P., Zhang, Q., Tabak, F., Streinu, A., Wang, J.-Y., Idılman, R., Reesink, H. W., et al. (2014) · Journal of Hepatology · doi:10.1016/s0168-8278(14)60005-2 · Cited by 13
Ahn, S. H., Marcellin, P., Ma, X., Căruntu, F. A., Tak, W. Y., Elkhashab, M., Chuang, W., Tabak, F., Mehta, R. M., Petersen, J., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)00924-7 · Cited by 12
Cited by
Loomba, R., & Liang, T. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.009 · Cited by 594
Self-citationTherapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Self-citationEpidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.006 · Cited by 366
Self-citationHIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment
Singh, K. P., Crane, M., Audsley, J., Avihingsanon, A., Sasadeusz, J., & Lewin, S. R. (2017) · AIDS · doi:10.1097/qad.0000000000001574 · Cited by 268
Long-term functional maintenance of primary human hepatocytes in vitro
Xiang, C., Du, Y., Meng, G., Soon Yi, L., Sun, S., Song, N., Zhang, X., Xiao, Y., Wang, J., Yi, Z., et al. (2019) · Science · doi:10.1126/science.aau7307 · Cited by 223
Metadata
- Authors
- Liang, T. J., Block, T. M., McMahon, B. J., Ghany, M. G., Urban, S., Guo, J., Locarnini, S., Zoulim, F., Chang, K., & Lok, A. S.
- Venue
- Hepatology
- Published
- 2015-10-27
- Volume
- 62
- Issue
- 6
- Pages
- 1893-1908
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1918954877
- Cited by
- 317
- References
- 139
- FWCI
- 26.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.